Expand VKTX Menu
VKTX MENU

VKTX Stock Posts


VKTX #VikingTherapeutics stock increases 4.6% after hours.

After Hours Gainer

VKTX Viking Therapeutics51.51+2.40+4.9%

After Hours:53.90+2.39 (+4.6%)

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024

PRNewswireTue, 19-Nov 4:03 PM

VKTX #VikingTherapeutics stock increases 5.1% after hours.

After Hours Gainer

VKTX Viking Therapeutics51.51+2.40+4.9%

After Hours:54.15+2.64 (+5.1%)

Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting 2024

PRNewswireTue, 19-Nov 4:03 PM

Unusual Option Volume

VKTX Viking Therapeutics66.27+3.13 (+5.0%)

Viking Therapeutics trades 14,445 contracts. The company has the following event: Truist Healthcare Conference on Nov 7, 2024.
Sentiment Alert: VKTX Increasing bearish pressure with an imbalance in net option delta of -487 K.

Bullish play with a target stock price of $100 or above

Strategy has +300% upside potential and 1488% overvalued

Unusual Option Volume

VKTX Viking Therapeutics76.02+3.14 (+4.3%)

Viking Therapeutics trades 9,453 contracts. The company has the following event: Truist Healthcare Conference on Nov 7, 2024. News: Viking Therapeutics Reports New Data from VK2735 Obesity Program at ObesityWeek 2024